"Kometrik" (kabozantinib), 140 mg: analogues qiimaha. Halkee si ay u iibsadaan ka jaban "Kometrik"?

"Kometrik" - daroogada taas oo ku salaysan yahay kabozantinib. Xarunta Tani waa inhibitor a awood of kinases cyclin ku tiirsan, jidaynayey si ay si guul leh u isticmaalaa in lagu daaweeyo qaab dagaal badan ee kansarka thyroid, oo loo yaqaan carcinoma medullary.

cudurada la odhan jiray inta badan saameeyaa dumarka dayska iyo waxa lagu gartaa koritaanka saa'idka ah iyo gaar ahaan malignant. Oo aan ka baxsan kaabsolka, metastases carcinoma si firfircoon ku fidaa xitaa xubnaha fog.

Kabozantinib awoodaan in ay la xakameeyo horumarinta metastases. Intaa waxaa dheer, waxa uu hakiyo koritaanka buro kansar qayb vascular.

imtixaanada, kaas oo la sameeyay 2015, waxay muujiyeen waxqabad ee daroogada ayaa sheegay in daawaynta kansarka kelyaha, kansarka qanjirka 'prostate', iyo sidoo kale in dagaalka ka dhanka ah burooyinka halista ah ee sambabada iyo maskaxda Aadanaha.

Halka aad karaa "Kometrik" iibsadaan ka jaban

Ku tilmaamay by yahay dabcan waxaa loola jeedaa heer sare ah. Laakiin qiimaha waxaa loogu talagalay cadeeyn kara in uu awoodi ugu of baahida loo qabo in si degdeg ah bukaanada daroogada this. Sidaas daraaddeed, in Moscow "Kometrik" (kabozantinib) qiimaha Waxaa ay ku bilaabataa laga bilaabo 380 000 mari., Taas oo, sida aad ogtahay, wuxuu keeni karaa dhibaatooyin for kuwa doonaya in ay iibsadaan.

Xaaladdan oo kale, waxaad u iman doonaan inay gargaar ah ee website a oo rikoor fiican track WWW.ONKO24.COM. Waxay bixisaa liisanka soo saaray shirkadaha Indian si fiican u yaqaan xabbo wakiilada anti-kansarka caan ah. Ogsoonow in generic ah - a daroogada dhamaystiran analoogga ku tilmaamay. Waxa uu leeyahay Halabuurka la mid ah, oo halkan ka, ah waxtarkeeda ma noqon karto in shaki. kharashka A hoose ay sabab u tahay xaqiiqada ah in shirkadda ayaa heshay xaq u leeyahay inuu soo saaro daroogada this, ma jiraan wax u baahan in ay maal-cilmi-baarista iyo advertising.

Shirkadaha sidaas daraaddeed aasaasay saara generic "Kometrik" daroogada (kabozantinib), qiimaha kiis kasta ma aha calaamad u ah in ay tayo liita iyo hufnaan u hooseeya.

Features of codsiga

Kometrik (Kabozantinib) 140 mg maamulka afka. Its dose ugu yar - 60 mg maalintii. Laakiin inta badan dhan waxaan ka hadleynaa qaadashada 140 mg ee horyaalka ka dhigan in 24-ka saac. In kasta oo kiis kasta waa in la go'aamiyey oo kaliya uu dhakhtarka xaadirka ah. Marka ay tani waa la tixgeliyaa ma aha oo kaliya qofka bukaanka ah, Laakiinse dhagaxii miisaanka iyo sifooyinka uu cadaanyo daroogada.

In daaweynta bukaanka kansarka laguma talinayo for 2 h. Ka hor inta aan la helo hab "Kometrik" iyo 1 hr. Ka dib. Waxaa muhiim ah in ay tixgeliyaan xaqiiqada ah in daaweyn jiray qalab ay u baahan tahay ka saarida ka cunto ee bukaan-socodka, iyo midhaha juice bambeelmo iyaga ka dhigay.

sababo

Kometrik (kabozantinib) 140 mg aan la tilmaamay in kiisaska fursado bukaan-socodka ah xinjiro dhiig, cudurka dhiig karka ama osteolysis ee lafta.

Ahaan uu si loogu soo daweeyo ka mid ah wakiilka iyo bukaanada ku jira xasaasiyad kasta oo ka mid ah qaybaha, kuwa nuujinaya, haweenka iyo bukaanka ka yar 18 sano uurka leh ay.

waxyeellooyin

dhibaatooyinka ka qaadashada kaabsoosha "Kometrik" (kabozantinib) 140 mg waa sida soo socota:

• dhacdo of goydey ee mareenka caloosha iyo mindhicirka iyo dhiig bax gudaha ah,
• osteonecrosis lafaha daanka,
• koritaanka AD,
• unugyada xadgudub guryaha regenerative;
• horumarinta cudurada cerebrovascular chronic;
• shuban;
• miisaanka oo yaraada;
• matag,
• gacanta-foot syndrome,
• rabshooyin nidaamka wadnaha.

Laakiin heli karo si "Kometrik" (kabozantinib) dib u eegista Waxa ay xoogga saareysaa in ay isticmaalka ogolaanaya in la kordhiyo muddada koritaanka aan buro labanlaab marka la barbardhigo kuwa kiisaska daawooyinka anticancer caadiga ah waxaa loo isticmaalaa. Intaa waxaa dheer, bukaanno badan waxay ku andacoodaan in qalab this sidoo kale waxay leedahay saameyn xanuunka, ogolaaneysa in la siiyo ilaa morphine.